Accoding to ICICIdirect.com, Apollo Hospitals Enterprises has a target price of Rs 471.

ICICIdirect.com's report on Apollo Hospitals Enterprises:

Apollo Hospitals reported its Q2FY09 results with net profit of Rs 30.13 crore led by better revenue growth and rise in other income. At the current price of Rs 411, the stock is trading at 14.9x its FY09E EV/EBITDA and at 11.1x its FY10E EV/EBITDA. We believe the current levels are attractive and have arrived at our target price of Rs 471 through our DCF valuation. At this price, the stock is available at 2.15x and 1.92x its FY09E and FY10E book value per share, respectively. We rate the stock as ‘PERFORMER’.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment......